(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.35% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.57%.
Embecta's revenue in 2025 is $1,079,500,000.On average, 1 Wall Street analysts forecast EMBC's revenue for 2025 to be $63,418,420,016, with the lowest EMBC revenue forecast at $63,418,420,016, and the highest EMBC revenue forecast at $63,418,420,016. On average, 1 Wall Street analysts forecast EMBC's revenue for 2026 to be $63,447,816,598, with the lowest EMBC revenue forecast at $63,447,816,598, and the highest EMBC revenue forecast at $63,447,816,598.
In 2027, EMBC is forecast to generate $63,815,419,973 in revenue, with the lowest revenue forecast at $63,815,419,973 and the highest revenue forecast at $63,815,419,973.